Distinct germ line polymorphisms underlie glioma morphologic heterogeneity

Cancer Genetics

Volumn 204, Issue 1, 2011, Pages 13-18

  Jenkins, Robert B ^a   Wrensch, Margaret R ^b   Johnson, Derek ^a   Fridley, Brooke L ^a   Decker, Paul A ^a   Xiao, Yuanyuan ^b   Kollmeyer, Thomas M ^a   Rynearson, Amanda L ^a   Fink, Stephanie ^a   Rice, Terri ^b   McCoy, Lucie S ^b   Halder, Chandralekha ^a   Kosel, Matthew L ^a   Giannini, Caterina ^a   Tihan, Tarik ^c   O'Neill, Brian P ^a   Lachance, Daniel H ^a   Yang, Ping ^a   Wiemels, Joseph ^b   Wiencke, John K ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1p 19q deletion; Genetic association; Glioma

Indexed keywords

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INFILTRATION; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 20Q; CHROMOSOME 8Q; CHROMOSOME DELETION; CHROMOSOME MAP; CHROMOSOME STRUCTURE; CONTROLLED STUDY; GENE DELETION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GERM LINE; GLIOMA; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MICROMORPHOLOGY; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; ALLELE; BRAIN TUMOR; CASE CONTROL STUDY; CHROMOSOME 1; CHROMOSOME 19; FEMALE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GLIOBLASTOMA; MALE; RISK;

ADULT; ALLELES; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 79955664968     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.10.002     Document Type: Article

References (23)

1. 2010 Central Brain Tumor Registry of the United States Available at: http://www.cbtrus.org/reports/reports.html.Accessed on September 9, 2010.
2. Bahuau M, Vidaud D, Jenkins RB, et al. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 1998;58:2298-2303.
3. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009;41:899-904.
4. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009;41:905-908.
5. Landi MT, Chatterjee N, Yu K, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009;85:679-691.
6. Song H, Ramus SJ, Tyrer J, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009;41:996-1000.
7. Goldin LR, Bjorkholm M, Kristinsson SY, et al. Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms. Genome Med 2009;1:55.
8. Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000; 18:636-645.
9. Felini MJ, Olshan AF, Schroeder JC, et al. Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 2009;20:87-96.
10. Wrensch M, McMillan A, Wiencke J, et al. Nonsynonymous coding single-nucleotide polymorphisms spanning the genome in relation to glioblastoma survival and age at diagnosis. Clin Cancer Res 2007;13:197-205.
11. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
12. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000;155: 945-959.
13. Yan H, Bigner DD, Velculescu V, et al. Mutant metabolic enzymes are at the origin of gliomas. Cancer Res 2009;69: 9157-9159.
14. Watanabe T, Nobusawa S, Kleihues P, et al. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 2009;174:1149-1153.
15. Noushmehr H, Weisenberger DJ, Diefes K, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010;17:510-522
16. Kiemeney LA, Thorlacius S, Sulem P, et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008;40:1307-1312.
17. Tsuchiya N, Slezak JM, Lieber MM, et al. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer 2002;34:363-371.
18. Barber LJ, Youds JL, Ward JD, et al. RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 2008; 135:261-271.
19. Sfeir A, Kosiyatrakul ST, Hockemeyer D, et al. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 2009;138:90-103.
20. Charbaut E, Curmi PA, Ozon S, et al. Stathmin family proteins display specific molecular and tubulin binding properties. J Biol Chem 2001;276:16146-16154.
21. Ozon S, Byk T, Sobel A. SCLIP: a novel SCG10-like protein of the stathmin family expressed in the nervous system. J Neurochem 1998;70:2386-2396.
22. Singer S, Malz M, Herpel E, et al. Coordinated expression of stathmin family members by far upstream sequence elementbinding protein-1 increases motility in nonesmall cell lung cancer. Cancer Res 2009;69:2234-2243.
23. International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449: 851-861